SCHEMBL509266

SCHEMBL509266

CCNNCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL899427 0.97
SCHEMBL8352247 0.84 LDHA (0.50)
SCHEMBL10904373 0.83 FFAR3 (0.38)
SCHEMBL28074944 0.78
SCHEMBL27063346 0.74
SCHEMBL15871536 0.74 ALOX15 (0.46)
SCHEMBL432430 0.73
SCHEMBL41068 0.73
SCHEMBL28310136 0.72 EPHX1 (0.46)
SCHEMBL26803252 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2628741-A2 NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR JW Pharmaceutical Corporation (KR) 2013-08-21 EP claimed
US-20130196972-A1 NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR JW PHARMACEUTICAL CORPORATION (KR) 2013-08-01 US claimed
EP-2419430-A2 NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF JW Pharmaceutical Corporation (KR) 2012-02-22 EP claimed
US-20100267672-A1 NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF CHOONGWAE PHARMA CORPORATION (KR) 2010-10-21 US claimed
WO-2010120112-A2 NOVEL COMPOUNDS OF REVERSE-TURN MIMETICS, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF CHOONGWAE PHARMA CORPORATION (KR) 2010-10-21 WO claimed
CN-100560626-C A kind of antirust emulsion of self-crosslinked interpenetrating net polymer and preparation method thereof HARBIN INST OF TECHNOLOGY (CN) 2009-11-18 CN claimed
CN-101029115-A Antirust emulsion of self-crosslinked interpenetrating net polymer and its production UNIV HARBIN POLYTECHNIC (CN) 2007-09-05 CN claimed
US-20050085417-A1 Compounds and methods for diagnostic imaging and therapy THOMAS JEFFERSON UNIVERSITY (US) 2005-04-21 US claimed
WO-2019118727-A2 RESCUE OF THE PATHOLOGY OF LRRK2 ON LYSOSMES WITH SNX25 OR SNX27 THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-06-20 WO disclosed
EP-2491036-B1 1,4-substituted 6-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidine derivatives as phosphoinositide-3-kinase inhibitors (PI3K) for treating allergies and asthma MERCK PATENT GMBH (DE) 2017-07-19 EP disclosed
US-20150337030-A1 METHODS TO TREAT ALZHEIMER'S DISEASE USING APOE INHIBITORS UNIV COLUMBIA (US) 2015-11-26 US disclosed
EP-2628741-B1 NOVEL COMPOUND OF A REVERSE-TURN MIMETIC AND A PRODUCTION METHOD AND USE THEREFOR JW PHARMACEUTICAL CORP (KR) 2015-10-07 EP disclosed
US-20150094215-A1 MODULATION OF LINE-1 REVERSE TRANSCRIPTASE UNIVERSITY OF HAWAII 2015-04-02 US disclosed
US-8940739-B2 Compound of a reverse-turn mimetic and a production method and use therefor JW PHARMACEUTICAL CORPORATION (KR) 2015-01-27 US disclosed
EP-0857791-A1 Method of analysis using signal amplification Roche Diagnostics GmbH (DE) 1998-08-12 EP disclosed
EP-0849363-A1 Method of identifying a nucleic acid using triple helix formation of adjacently annealed probes Roche Diagnostics GmbH (DE) 1998-06-24 EP disclosed
EP-0632722-A4 A DNA TRANSPORTER SYSTEM AND METHOD OF USE. BAYLOR COLLEGE MEDICINE (US) 1997-07-30 EP disclosed
EP-0632722-A1 A DNA TRANSPORTER SYSTEM AND METHOD OF USE BAYLOR COLLEGE OF MEDICINE (US) 1995-01-11 EP disclosed
WO-1993018759-A1 A DNA TRANSPORTER SYSTEM AND METHOD OF USE BAYLOR COLLEGE OF MEDICINE (US) 1993-09-30 WO disclosed
CN-1071931-A The preparation of copolymer latices TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-05-12 CN disclosed